Trial of Dexmethylphenidate (Focalin) ER in ADHD
Abstract
The efficacy and safety of dexmethylphenidate extended release (d-MPH-ER) was compared to placebo in 97 patients (ages 6-17 years) with attention-deficit/hyperactivity disorder (ADHD) in a multicenter, randomized, double-blind, two-phase study reported from New York State Psychiatric Institute, New York.
DOI: https://doi.org/10.15844/pedneurbriefs-20-7-7 | Journal eISSN: 2166-6482
Language: English
Page range: 54 - 55
Published on: Jul 1, 2006
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
© 2006 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.